Skip to main content

Table 5 The relations between polymorphism site of LINC02122 rs10036719 and prognosis of patients with GC

From: lncRNA polymorphism affects the prognosis of gastric cancer

rs10036719

N

MST (M)

Survival rate (%)

HR (95% CI)

P

1-year

3-year

5-year

Codominance

 GG

45

19.00

66.67

45.67

41.70

1

0.093

 AG

155

28.00

75.41

42.03

36.89

0.851 (0.555–1.303)

0.458

 AA

144

34.00

73.52

48.99

41.31

0.654 (0.422–1.012)

0.057

Allele gene

 G

245

28.00

72.19

43.27

38.54

1

0.029*

 A

443

31.00

74.18

46.59

39.79

0.796 (0.649–0.977)

 

Dominant model

 GG

45

19.00

66.67

45.67

41.70

1

0.161

 AG+AA

299

30.00

74.50

45.42

39.05

0.749 (0.5–1.122)

 

Recessive model

 GG+AG

200

28.00

73.43

42.78

37.88

1

0.042*

 AA

144

34.00

73.52

48.99

41.31

0.742 (0.556–0.989)

 
  1. *P was adjusted according to age, sex, TNM stage, operation, and chemotherapy